BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22425739)

  • 1. The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function.
    Boggio E; Melensi M; Bocca S; Chiocchetti A; Comi C; Clemente N; Orilieri E; Soluri MF; D'Alfonso S; Mechelli R; Gentile G; Poggi A; Salvetti M; Ramenghi U; Dianzani U
    Hum Immunol; 2012 May; 73(5):585-92. PubMed ID: 22425739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.
    Martínez-Feito A; Melero J; Mora-Díaz S; Rodríguez-Vigil C; Elduayen R; González-Granado LI; Pérez-Méndez D; Sánchez-Zapardiel E; Ruiz-García R; Menchén M; Díaz-Madroñero J; Paz-Artal E; Del Orbe-Barreto R; Riñón M; Allende LM
    Immunobiology; 2016 Jan; 221(1):40-7. PubMed ID: 26323380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes.
    Boggio E; Clemente N; Mondino A; Cappellano G; Orilieri E; Gigliotti CL; Toth E; Ramenghi U; Dianzani U; Chiocchetti A
    Blood; 2014 Feb; 123(8):1178-86. PubMed ID: 24363402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function.
    Clementi R; Chiocchetti A; Cappellano G; Cerutti E; Ferretti M; Orilieri E; Dianzani I; Ferrarini M; Bregni M; Danesino C; Bozzi V; Putti MC; Cerutti F; Cometa A; Locatelli F; Maccario R; Ramenghi U; Dianzani U
    Blood; 2006 Nov; 108(9):3079-84. PubMed ID: 16720836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype.
    Boggio E; Aricò M; Melensi M; Dianzani I; Ramenghi U; Dianzani U; Chiocchetti A
    Pediatrics; 2013 Oct; 132(4):e1052-8. PubMed ID: 24043286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations of the UNC13D gene in patients with autoimmune lymphoproliferative syndrome.
    Aricò M; Boggio E; Cetica V; Melensi M; Orilieri E; Clemente N; Cappellano G; Buttini S; Soluri MF; Comi C; Dufour C; Pende D; Dianzani I; Ellis SR; Pagliano S; Marcenaro S; Ramenghi U; Chiocchetti A; Dianzani U
    PLoS One; 2013; 8(7):e68045. PubMed ID: 23840885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCF1 deficiency ameliorates autoimmune lymphoproliferative syndrome (ALPS)-like phenotypes of lpr/lpr mice.
    Xu X; Yu B; Cai W; Huang Z
    Scand J Immunol; 2017 Jun; 85(6):406-416. PubMed ID: 28349581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of miR-146a/FAS and miR-21/FASLG axes in autoimmune lymphoproliferative syndrome due to FAS mutation (ALPS-FAS).
    Marega LF; Teocchi MA; Dos Santos Vilela MM
    Clin Exp Immunol; 2016 Aug; 185(2):148-53. PubMed ID: 27060458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in autoimmune lymphoproliferative syndromes.
    Madkaikar M; Mhatre S; Gupta M; Ghosh K
    Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.
    Fuss IJ; Strober W; Dale JK; Fritz S; Pearlstein GR; Puck JM; Lenardo MJ; Straus SE
    J Immunol; 1997 Feb; 158(4):1912-8. PubMed ID: 9029133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
    Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
    Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of SLAM mutations in EBV-associated lymphoproliferative disease patients.
    Ferrand V; Li C; Romeo G; Yin L
    J Med Virol; 2003 May; 70(1):131-6. PubMed ID: 12629654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAS -670 A/G polymorphism may be associated with the depletion of CD4(+) T lymphocytes in HIV-1 infection.
    Hermes RB; Santana BB; Lima SS; Neris Martins Feitosa R; de Oliveira Guimarães Ishak M; Ishak R; Vallinoto AC
    Hum Immunol; 2015 Oct; 76(10):742-6. PubMed ID: 26429326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLAM-SAP signaling promotes differentiation of IL-17-producing T cells and progression of experimental autoimmune encephalomyelitis.
    Huang YH; Tsai K; Ma C; Vallance BA; Priatel JJ; Tan R
    J Immunol; 2014 Dec; 193(12):5841-53. PubMed ID: 25362182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutation.
    Del-Rey MJ; Manzanares J; Bosque A; Aguiló JI; Gómez-Rial J; Roldan E; Serrano A; Anel A; Paz-Artal E; Allende LM
    Immunobiology; 2007; 212(2):73-83. PubMed ID: 17336828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation.
    Chiocchetti A; Indelicato M; Bensi T; Mesturini R; Giordano M; Sametti S; Castelli L; Bottarel F; Mazzarino MC; Garbarini L; Giacopelli F; Valesini G; Santoro C; Dianzani I; Ramenghi U; Dianzani U
    Blood; 2004 Feb; 103(4):1376-82. PubMed ID: 14592838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
    Puck JM; Sneller MC
    Semin Immunol; 1997 Feb; 9(1):77-84. PubMed ID: 9106310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of inherited defects decreasing Fas function in autoimmunity.
    Dianzani U; Chiocchetti A; Ramenghi U
    Life Sci; 2003 May; 72(25):2803-24. PubMed ID: 12697265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease.
    Erdõs M; Uzvölgyi E; Nemes Z; Török O; Rákóczi E; Went-Sümegi N; Sümegi J; Maródi L
    Hum Mutat; 2005 May; 25(5):506. PubMed ID: 15841490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.